伊瓦布拉丁:作为抗心律失常剂的作用正在演变
1Division of Cardiology, The Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
伊瓦布拉丁有效地降低了心率,并显示出作为抗心律失常治疗的前景. 本综述探讨了其当前和潜在的用途,重点是儿科数据,但包括成人研究.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊瓦布拉丁是一种选择性心率降低剂.
- 它在治疗心律失常方面的作用正在扩大.
研究的目的:
- 审查关于伊瓦布拉丁抗心律失常功效的现有证据.
- 讨论其临床应用,特别是在儿科.
主要方法:
- 临床研究的文献综述.
- 对艾瓦布拉丁疗效的儿科和成人数据的分析.
主要成果:
- 证据支持伊瓦布拉丁作为抗心律失常药的实用性.
- 在儿科人口中存在显著的临床经验.
结论:
- 伊瓦布拉丁是一种有价值的抗心律失常剂.
- 进一步调查其更广泛的应用是有必要的.
更多相关视频
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
